✅ INFORMED CONSENT FORM (ICF)
🔹 Definition
Informed consent is a mandatory ethical
and legal process in research involving human subjects.
It ensures that participants voluntarily agree to participate
after understanding all aspects of the study.
🔹 Importance
- Protects rights,
safety, and well-being of participants
- Ensures transparency
in research
- Required by Ethics
Committee/IRB approval
- Maintains legal and
ethical compliance
📝 FORMAT AND STYLE OF ICF
- Written in 2nd person
(“You”)
- Avoid starting sentences with “You
understand…”
- Use simple, layman
language
- Avoid technical/medical jargon
(or explain clearly if used)
- Use 12-point font
(larger for elderly/children if needed)
- Must be typed (not
handwritten)
- May include:
- Tables
- Flowcharts (for better
understanding)
- Must include:
- Participant signature
- Investigator signature
- Date
- Witness signature
(if applicable)
📋 COMPONENTS OF INFORMED CONSENT FORM
1.
PURPOSE OF THE STUDY
- Explain in simple terms
- Clearly state:
- Why the study is being done
- That it is research
- Define terms like:
- Randomization
- Double-blind
- Placebo-controlled
2.
PROCEDURES
- Describe:
- Study steps and activities
- Duration of participation
- Include:
- Inclusion & exclusion
criteria
- Tests/interviews/questionnaires
- Add table/flowchart
if helpful
3.
RISKS AND DISCOMFORTS
- Mention:
- Physical risks
- Psychological risks
- Social/economic risks
- Include:
- Foreseeable risks
- Unforeseeable risks statement
- Example: blood collection risks
4.
BENEFITS
- Describe expected benefits:
- To participant
- To society/science ⚠️
Note:
- Compensation
≠ Benefit
- Free
treatment ≠ Benefit
5.
COMPENSATION / COSTS / REIMBURSEMENT
- Mention:
- Payment (if any)
- Travel reimbursement
- Clearly state:
- Any extra costs
to participant
6.
WITHDRAWAL FROM STUDY
- Participant can:
- Withdraw anytime
without penalty
- Mention:
- Conditions for investigator
termination
- Safe withdrawal procedures
7.
CONFIDENTIALITY
- Explain:
- How data will be protected
- Who can access data
- Assure:
- Privacy of participant
identity
8.
NEW FINDINGS
- Participants will be informed
if:
- New information affects their
decision to continue
9.
ALTERNATIVES TO PARTICIPATION
- Explain:
- Other treatment options (if
applicable)
- Option to refuse participation
10.
COMPENSATION FOR INJURY
- State:
- Treatment/compensation if
injury occurs
- Applicable mainly in clinical
trials
11.
OTHER CONSIDERATIONS
- Disclose:
- Financial conflicts of
interest
- Include:
- Information about biological
sample collection (if any)
12.
CONTACT INFORMATION
- Provide:
- Investigator contact details
- Ethics Committee/Research
Office contact
13.
VOLUNTARY PARTICIPATION
- Clearly state:
- Participation is completely
voluntary
- No penalty for refusal or
withdrawal
14.
SIGNATURES
Include:
- Participant
- Investigator
- Legally
Authorized Representative (LAR) (if
needed)
- Witness
(in specific cases)
- For minors:
- Parent/guardian consent
- Assent (age 13–17)
⚖️ WAIVER OF WRITTEN INFORMED CONSENT
IRB may waive signed consent if:
✔ Condition 1:
- Only link to participant is
consent document
- Main risk = breach of
confidentiality
- Participant decides if
documentation is needed
✔ Condition 2:
- Study involves minimal
risk
- No procedures requiring written
consent outside research
➡️ Participants may still receive
an information sheet
⚖️ WAIVER / ALTERATION OF INFORMED CONSENT
IRB can waive or modify consent if:
- Study involves minimal
risk
- Does not affect participant
rights/welfare
- Not feasible without waiver
- Participants are informed later
(if required)
- Not applicable to FDA-regulated
clinical trials
🔑 EXAM QUICK POINTS
- Always written in 2nd
person
- Use simple language
- Must include risks,
benefits, confidentiality
- Voluntary
participation is essential
- IRB
approval required
- Waiver allowed only under strict
conditions
No comments:
Post a Comment